×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DWTX – dogwood therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DWTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/26
01:14 pm
dwtx
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight [Yahoo! Finance]
Low
Report
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight [Yahoo! Finance]
11/6
08:45 am
dwtx
Dogwood Therapeutics Reports Third Quarter 2025 Financial Results
Medium
Report
Dogwood Therapeutics Reports Third Quarter 2025 Financial Results
10/8
12:19 pm
dwtx
Dogwood Therapeutics (NASDAQ:DWTX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Dogwood Therapeutics (NASDAQ:DWTX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
10/7
09:10 am
dwtx
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit [Yahoo! Finance]
Medium
Report
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit [Yahoo! Finance]
9/30
08:06 am
dwtx
Dogwood Therapeutics (NASDAQ:DWTX) had its price target raised by analysts at HC Wainwright from $10.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
Dogwood Therapeutics (NASDAQ:DWTX) had its price target raised by analysts at HC Wainwright from $10.00 to $12.00. They now have a "buy" rating on the stock.
9/29
08:03 am
dwtx
Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients [Y
High
Report
Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients [Y
9/29
07:15 am
dwtx
Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company’s Dedication to Improving the Lives of Cancer Patients
High
Report
Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company’s Dedication to Improving the Lives of Cancer Patients
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
08:45 am
dwtx
dogwood therapeutics, inc.
MISS
Report
-7.6%
dogwood therapeutics, inc.
8/13/2025
09:00 am
dwtx
dogwood therapeutics, inc.
MISS
Report
1.9%
dogwood therapeutics, inc.
5/8/2025
09:00 am
dwtx
dogwood therapeutics, inc.
MISS
Report
-1.3%
dogwood therapeutics, inc.
3/31/2025
03:45 pm
dwtx
dogwood therapeutics, inc.
MISS
Report
0.8%
dogwood therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/28
02:15 pm
dwtx
Form 8-K Dogwood Therapeutics, For: Nov 28
Neutral
Report
Form 8-K Dogwood Therapeutics, For: Nov 28
11/28
02:01 pm
dwtx
Form 424B5 Dogwood Therapeutics,
Neutral
Report
Form 424B5 Dogwood Therapeutics,
11/25
05:40 pm
dwtx
Form 4 Dogwood Therapeutics, For: Nov 21 Filed by: Conjoint Inc.
Low
Report
Form 4 Dogwood Therapeutics, For: Nov 21 Filed by: Conjoint Inc.
11/25
05:30 pm
dwtx
Form SCHEDULE 13D/A Dogwood Therapeutics, Filed by: Sealbond Ltd
Low
Report
Form SCHEDULE 13D/A Dogwood Therapeutics, Filed by: Sealbond Ltd
11/21
01:01 pm
dwtx
Form 8-K Dogwood Therapeutics, For: Nov 21
Low
Report
Form 8-K Dogwood Therapeutics, For: Nov 21
11/7
08:46 am
dwtx
Form 10-Q Dogwood Therapeutics, For: Sep 30
Low
Report
Form 10-Q Dogwood Therapeutics, For: Sep 30
11/6
09:15 am
dwtx
Form 8-K Dogwood Therapeutics, For: Nov 06
Medium
Report
Form 8-K Dogwood Therapeutics, For: Nov 06
10/20
05:26 pm
dwtx
Form DEF 14A Dogwood Therapeutics, For: Nov 21
High
Report
Form DEF 14A Dogwood Therapeutics, For: Nov 21
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: